Skip to main content
. 2011 Mar;178(3):1287–1297. doi: 10.1016/j.ajpath.2010.11.071

Figure 5.

Figure 5

Effects of sActRIIB therapy on circulating CK levels. The mdx mice treated with the 10.0 mg/kg−1 dose of sActRIIB had a significantly lower concentration of serum CK compared with control mdx mice. ***P < 0.0001.

HHS Vulnerability Disclosure